apollo
0
  1. Home
  2. Medicine
  3. Baraclude 0.5 mg Oral Solution 210 ML

Prescription drug
 Trailing icon
coupon
coupon
coupon
Extra 15% Off with Bank Offers
Written By ,
Reviewed By Bayyarapu Mahesh Kumar , M Pharmacy

Baraclude 0.5 mg Oral Solution is used to treat chronic hepatitis B virus (HBV) infection. It helps reduce the amount of virus in the body, prevents further liver damage, and supports long-term liver health. With regular use, it lowers the risk of complications such as cirrhosis and liver failure, helping to slow the progression of liver disease.

Read more

Composition :

ENTECAVIR-0.05MG

Manufacturer/Marketer :

Bristol-Myers Squibb India Pvt Ltd

Consume Type :

ORAL

Return Policy :

Not Returnable

Expires on or after :

About Baraclude 0.5 mg Oral Solution

Baraclude 0.5 mg Oral Solution is used to treat chronic hepatitis B virus (HBV) infection. Hepatitis B is a severe liver infection caused by the hepatitis B virus (HBV). It is highly contagious and spreads through intimate contact with the infected person and direct contact with infected blood.

Baraclude 0.5 mg Oral Solution contains Entecavir, which helps prevent the virus from replicating and reduces the amount of hepatitis B virus in the body.

Take Baraclude 0.5 mg Oral Solution as advised by the doctor. In some cases, you may experience dizziness, headache, nausea, vomiting, drowsiness, extreme tiredness, inability to sleep, diarrhoea, or indigestion. Most of these side effects do not require medical attention. However, if the side effects worsen, please consult your doctor.

If you are allergic to Baraclude 0.5 mg Oral Solution or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please consult a doctor before taking Baraclude 0.5 mg Oral Solution . It is recommended to use effective contraceptive methods while using Baraclude 0.5 mg Oral Solution to avoid pregnancy. If you have HIV/AIDS, kidney or liver problems, inform your doctor before taking Baraclude 0.5 mg Oral Solution .

Uses of Baraclude 0.5 mg Oral Solution

Baraclude 0.5 mg Oral Solution is used for the treatment of chronic (long-term) hepatitis B virus (HBV) infection. The detailed uses of Baraclude 0.5 mg Oral Solution are as follows:

  • Treatment of Chronic HBV Infection: Baraclude 0.5 mg Oral Solution is indicated for adults with chronic HBV infection, including those with compensated liver disease (where the liver is damaged but still functions) and decompensated liver disease (where the liver is severely damaged and no longer functions properly)

Have a query?

Directions for Use

  • Baraclude 0.5 mg Oral Solution can be taken on an empty stomach, preferably 2 hours before or after a meal.
  • It is usually taken once daily at the same time each day or as prescribed by your doctor.
  • Shake the bottle well before each use.
  • Use the measuring spoon provided with the pack to measure the dose accurately.
  • To use the spoon, hold it upright (vertically) and slowly fill it to the marking that matches your prescribed dose. With the volume markings facing you, verify that the spoon is filled to the correct mark. Take the medicine by mouth directly from the measuring spoon.
  • Rinse the spoon thoroughly with water and let it air dry after each use.
  • Avoid using regular household spoons, as they may not measure the dose correctly.

Medicinal Benefits

  • Effectively inhibits the growth of the hepatitis B virus (HBV).
  • Lowers ALT/AST levels and liver inflammation.
  • Inhibits or slows the development of cirrhosis.
  • Reduces the chance of hepatocellular carcinoma (liver cancer) and liver failure.
  • Enhances liver health over the long run with ongoing treatment.

How Baraclude 0.5 mg Oral Solution Works

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug. It works by inhibiting viral DNA polymerase enzyme action in the liver cells, which is essential for the virus to multiply. Therefore, it prevents the virus from replicating and reduces the amount of hepatitis B virus in the body.

Storage

• Store in a cool and dry place away from sunlight.• Keep Baraclude 0.5 mg Oral Solution out of the sight and reach of children. • Non cold chain - To be stored in cool places at 10ºC to 25ºC or below 30ºC.

What if I have taken an overdose of Baraclude 0.5 mg Oral Solution

An overdose of Baraclude 0.5 mg Oral Solution may cause unpleasant effects. If you think you have taken an overdose, contact your doctor or seek medical help right away.

Drug Warnings

  • If you are allergic to Baraclude 0.5 mg Oral Solution or any other medicines, please tell your doctor.
  • If you are pregnant or breastfeeding, please consult a doctor before taking Baraclude 0.5 mg Oral Solution .
  • It is recommended to use effective contraceptive methods while using Baraclude 0.5 mg Oral Solution to avoid pregnancy.
  • Baraclude 0.5 mg Oral Solution is not recommended for children below 2 years of age.
  • If you experience stomach pain, vomiting or nausea while taking Baraclude 0.5 mg Oral Solution , it might indicate the development of lactic acidosis. This rare but serious side effect has occasionally been fatal.
  • If you have HIV/AIDS or kidney or liver problems, inform your doctor before taking Baraclude 0.5 mg Oral Solution .

Diet & Lifestyle Advise

Healthy eating habits:

  • Eat a liver-friendly, well-balanced diet rich in fruits, vegetables, and healthy grains.
  • Reduce liver strain by limiting processed, fried, and fatty foods.
  • Eat meals at regular times and drink plenty of water.

Lifestyle changes:

  • Avoid alcohol entirely to safeguard your liver.
  • Maintain a healthy weight by engaging in moderate exercise.

Physical activity

  • Regularly engage in light-to-moderate exercise, such as yoga or walking.
  • To lessen liver strain, maintain a healthy weight.

Habit Forming

No

Therapeutic Class

ANTIVIRALS

bannner image

Alcohol

Consult your doctor

The interaction of alcohol with Baraclude 0.5 mg Oral Solution is unknown. Please consult a doctor before consuming alcohol while using Baraclude 0.5 mg Oral Solution .

bannner image

Pregnancy

Caution

Baraclude 0.5 mg Oral Solution is a category C pregnancy drug and is given to pregnant women only if the doctor thinks the benefits outweigh the risks.

bannner image

Breast Feeding

Consult your doctor

It is not known whether Baraclude 0.5 mg Oral Solution is excreted in human breast milk. Therefore, consult your doctor before using Baraclude 0.5 mg Oral Solution while breastfeeding. Your doctor will weigh the potential benefits against the possible risks before recommending its use during this time.

bannner image

Driving

Caution

Baraclude 0.5 mg Oral Solution may cause dizziness, drowsiness or tiredness in some people. Therefore, avoid driving or operating heavy machinery if you feel dizzy, drowsy or tired after taking Baraclude 0.5 mg Oral Solution .

bannner image

Liver

Caution

Take Baraclude 0.5 mg Oral Solution with caution, especially if you have liver problems. Your doctor may adjust the dose as required. Please consult a doctor.

bannner image

Kidney

Caution

Take Baraclude 0.5 mg Oral Solution with caution, especially if you have kidney problems. Your doctor may adjust the dose as required. Please consult a doctor.

bannner image

Children

Caution

Baraclude 0.5 mg Oral Solution is not recommended for children under 2 years of age or weighing less than 10 kg due to insufficient safety and effectiveness data. In children aged 2 years and above, Baraclude 0.5 mg Oral Solution should be used only under medical supervision, with doses strictly adjusted based on the child’s weight and clinical condition. Close monitoring of treatment response and potential side effects is essential.

bannner image

Heart

Caution

Baraclude 0.5 mg Oral Solution should be used with caution in patients with heart problems. Therefore, please consult your doctor before using Baraclude 0.5 mg Oral Solution .

bannner image

Geriatrics

Consult your doctor

Baraclude 0.5 mg Oral Solution is generally safe for geriatric people, but it requires dose adjustments and careful monitoring, particularly in those with age-related kidney impairment. Therefore, please consult your doctor before using Baraclude 0.5 mg Oral Solution .

FAQs

Baraclude 0.5 mg Oral Solution is an antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults and children aged 2 to 18 years.

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug that works by preventing the viral DNA polymerase enzyme action in the liver cells, which is essential for the virus to multiply. Therefore, it prevents the virus from replicating and reduces the amount of hepatitis B virus in the body.

Yes, hepatitis B virus infection is highly contagious and spreads from one person to another. Therefore, it is recommended to avoid sharing personal items or needles containing an infected person's blood or body fluids.

Baraclude 0.5 mg Oral Solution may cause lactic acidosis (excess of lactic acid in the blood), a rare but severe side effect, especially in women who are very obese. However, if you experience stomach pain, vomiting or nausea while taking Baraclude 0.5 mg Oral Solution , please consult a doctor immediately.

You are not recommended to take Baraclude 0.5 mg Oral Solution with celecoxib (painkiller), as it may increase the blood levels of Baraclude 0.5 mg Oral Solution , leading to more adverse effects and may also affect kidney function. However, please consult your doctor before taking Baraclude 0.5 mg Oral Solution with other medicines.

Baraclude 0.5 mg Oral Solution does not cure hepatitis B virus infection. However, it reduces the amount of hepatitis B virus in the body and improves liver functioning by decreasing liver damage.

Baraclude 0.5 mg Oral Solution is not recommended for hepatitis B patients with HIV infection unless they are taking medicines to treat HIV infection at the same time as Baraclude 0.5 mg Oral Solution may cause HIV infection to become resistant to certain HIV drugs and reduce their effectiveness. Therefore, it is advised to get tested for HIV infection before taking Baraclude 0.5 mg Oral Solution .

You are not recommended to stop taking Baraclude 0.5 mg Oral Solution without consulting your doctor, as it may worsen the infection or cause recurring symptoms. Therefore, take Baraclude 0.5 mg Oral Solution for as long as your doctor has prescribed it. If you experience any difficulty while taking Baraclude 0.5 mg Oral Solution , please consult your doctor.

Baraclude 0.5 mg Oral Solution may cause dizziness, headache, nausea, vomiting, drowsiness, extreme tiredness, inability to sleep, diarrhoea, or indigestion. Most of these side effects do not require medical attention. However, if the side effects worsen, please consult your doctor.

Country of origin

India

Manufacturer/Marketer address

Bristol-Myers Squibb India Pvt. Ltd., The India Bulls Finance Centre, 6th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (W), Mumbai - 400013
Other Info - BAR0096

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
whatsapp Floating Button